NM_001849.4(COL6A2):c.93C>T (p.Thr31=) AND Bethlem myopathy 1A
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jul 10, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002133500.5
-
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy ...
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review - NIHR Health Technology Assessment programme: Executive Summaries
-
LOC101740725 [Bombyx mori]
LOC101740725 [Bombyx mori]Gene ID:101740725Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Jun 17, 2024